Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor in Clopidogrel Resistant Hemodialysis Patients
NCT01511471Phase 3Completed
- Sponsor
- University of Patras
- Start
- Jan 2012
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ticagrelor in clopidogrel resistance (HTPR), sponsored by University of Patras. Primary endpoint: Platelet reactivity assessed by VerifyNow P2Y12 assay at Day 15. Started Jan 2012; status: completed.
02
Drugs
ticagrelor
03
Conditions
clopidogrel resistance (HTPR)
Beyond the preview
Go deeper on NCT01511471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511471.